Similar disparities in HR values were seen for outcomes of cardiac death, recurrent MI, and ischemic stroke (Figure 7, Figure 8 and Figure 9), as patients with high LL-37 and elevated lp(a) or PCSK9 acquired a numerically lower risk, although without statistical significance (all p > 0.05) or substantial interactions (all p interaction > 0.05). This evidence concerns the gene PCSK9 and ischemic stroke.